DAX24.231 +0,1%Est505.665 -0,1%MSCI World4.343 -0,1%Top 10 Crypto15,04 -1,0%Nas23.209 +1,2%Bitcoin94.683 -0,1%Euro1,1625 ±0,0%Öl66,50 +0,8%Gold4.129 +0,1%

Amicus Therapeutics Aktie

Kaufen

Verkaufen

Aktien-Sparplan anlegen Aktien-Sparplan anlegen

7,30 EUR +0,05 EUR +0,69 %

15:36:08

STU

8,62 USD +0,13 USD +1,47 %

16:48:59

BTT

Amicus Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)

Bei einem anderen Broker handeln

Smartphone

Marktkap.2,27 Mrd. EUR

Div. Rendite0,00%

WKNA0MSMZ

ISINUS03152W1099

SymbolFOLD

Amicus Therapeutics Aktien News

Sortieren:Datum Meistgelesen

07.10.25ZacksAll You Need to Know About Amicus Therapeutics (FOLD) Rating Upgrade to Strong Buy

07.10.25ZacksZacks.com featured highlights include Amicus Therapeutics, Micron Technology and General Dynamics

19.09.25ZacksStrength Seen in Amicus Therapeutics (FOLD): Can Its 6.4% Jump Turn into More Strength?

WerbungAmicus Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

05.08.25ZacksEarnings Estimates Moving Higher for Amicus Therapeutics (FOLD): Time to Buy?

05.08.25ZacksDoes Amicus Therapeutics (FOLD) Have the Potential to Rally 138.21% as Wall Street Analysts Expect?

31.07.25ZacksAmicus Therapeutics (FOLD) Misses Q2 Earnings Estimates

24.07.25ZacksAnalysts Estimate Amicus Therapeutics (FOLD) to Report a Decline in Earnings: What to Look Out for

10.07.25PR NewswireSHAREHOLDER NOTICE: Kaskela Law LLC Announces Shareholder Investigation of Amicus Therapeutics, Inc. (NASDAQ: FOLD) and Encourages Long-Term FOLD Investors to Contact the Firm

01.05.25ZacksAmicus Therapeutics (FOLD) Q1 Earnings and Revenues Lag Estimates

30.04.25BenzingaAmicus Therapeutics Earnings Preview

24.04.25ZacksAmicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

23.04.25ZacksAmicus Therapeutics to Report Q1 Earnings: What's in the Cards?

21.03.25ZacksAmicus Therapeutics (FOLD) Up 0.1% Since Last Earnings Report: Can It Continue?

20.02.25ZacksCompared to Estimates, Amicus Therapeutics (FOLD) Q4 Earnings: A Look at Key Metrics

19.02.25ZacksAmicus Therapeutics (FOLD) Q4 Earnings and Revenues Miss Estimates

17.02.25ZacksInsights Into Amicus Therapeutics (FOLD) Q4: Wall Street Projections for Key Metrics

12.02.25ZacksAmicus Therapeutics (FOLD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

13.01.25BenzingaA Glimpse Into The Expert Outlook On Amicus Therapeutics Through 6 Analysts

13.12.24ZacksAmicus Therapeutics (FOLD) is a Top-Ranked Momentum Stock: Should You Buy?

12.11.24BenzingaA Closer Look at 8 Analyst Recommendations For Amicus Therapeutics

12.11.24BenzingaThe Analyst Verdict: Amicus Therapeutics In The Eyes Of 8 Experts

12.11.24BenzingaAmicus Therapeutics Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)

07.11.24ZacksHere's Why Amicus Therapeutics (FOLD) is a Strong Momentum Stock

07.11.24BenzingaPeeling Back The Layers: Exploring Amicus Therapeutics Through Analyst Insights

07.11.24ZacksHere's What Key Metrics Tell Us About Amicus Therapeutics (FOLD) Q3 Earnings

06.11.24ZacksAmicus Therapeutics (FOLD) Q3 Earnings and Revenues Beat Estimates

04.11.24ZacksWall Street Analysts Predict a 51.09% Upside in Amicus Therapeutics (FOLD): Here's What You Should Know

30.10.24ZacksAmicus Therapeutics (FOLD) Reports Next Week: Wall Street Expects Earnings Growth

21.10.24ZacksWhy Amicus Therapeutics (FOLD) is a Top Momentum Stock for the Long-Term

18.10.24ZacksCan Amicus Therapeutics (FOLD) Run Higher on Rising Earnings Estimates?

18.10.24ZacksHow Much Upside is Left in Amicus Therapeutics (FOLD)? Wall Street Analysts Think 43.44%

18.10.24ZacksAmicus Therapeutics (FOLD) Just Flashed Golden Cross Signal: Do You Buy?

18.10.24ZacksAmicus Therapeutics (FOLD) Stock Jumps 14.0%: Will It Continue to Soar?

02.10.23PR NewswireWuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

14.11.22PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Amicus Therapeutics, Inc. - FOLD

Amicus Therapeutics News

Amicus Therapeutics News: auf dieser Seite finden Sie alle Amicus Therapeutics News und Nachrichten zur Amicus Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Amicus Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Amicus Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.